The future of heart disease treatment may change after a study found that a common post-heart attack medication may not be as ...

Pharmacists Corewell Health transforming heart failure care by accelerating medication optimization and improving patient outcomes in Michigan.

Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...

A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...

Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science session today at Heart Failure 2026, the annual congress of the Heart ...

Millions of people in the U.S. suffer from heart failure and that number is growing. South Carolina patients are at higher ...

Heart failure (HF) patients who have reduced or mildly reduced ejection fraction derive better outcomes when low-dose digoxin ...

Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Hearts can’t heal ...

What would you do if I told you there is drug widely available without prescription that kills almost 500 Americans every day ...

When the results of the SELECT trial landed in the New England Journal of Medicine in November 2023, they confirmed what ...

Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...